2015 American Transplant Congress
Donor Hemodynamic Profile Presages Graft Survival in Donation After Cardiac Death Liver Transplantation
Transplant Institute, Georgetown University Hospital, Washington, DC.
IntroductionDonation after cardiac death (DCD) grafts are prone to periods of prolonged hypoxemia and hypotension prior to donor expiration, leading to an increased complication rate,…2015 American Transplant Congress
Evaluation of the Effects of N-Acetylcysteine Treatment in Adult Liver Transplant Recipients
Aurora St Luke's Medical Center, Milwaukee, WI.
Background: N-acetylcysteine (NAC) has been used in post-orthotopic liver transplant (OLT) patients for the proposed mechanism of preventing tissue damage of the newly transplanted organ…2015 American Transplant Congress
Does BMI Affect Survival in Cadaveric Liver Transplantation for Benign Conditions?
Surgery, Dalhousie University, Halifax, NS, Canada.
Obesity is a relative contraindication to liver transplantation (LT). Aim of this study was to analyze morbidity, mortality, long-term survival of cadaveric LTs stratified by…2015 American Transplant Congress
Utilization and Characteristics of Liver Donors in the US by OPTN-Defined Increased Risk Donor Status
Background: The number of candidates in need of liver transplantation is far larger than the number of organ donors. To expand the organ pool, there…2015 American Transplant Congress
U.S. National Experience of Liver Transplantation Using Allografts from Octogenarian Donors
Surgery, Division of Transplantation, University of Illinois at Chicago, Chicago, IL.
IntroductionA continuous worsening of donor organ shortage has led to expand organ acceptance criteria. It is still theoretically possible to utilize hepatic allografts from donors…2015 American Transplant Congress
Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation
Endovascular treatment of hepatic artery stenosis (HAS) after liver transplantation offers a less invasive alternative to surgical revision or retransplantation. However, outcomes following endovascular treatment…2015 American Transplant Congress
Preventing Cytomegalovirus Infection in Intermediate-High Risk Liver Transplant Recipients: Acyclovir Vs Valganciclovir
Department of Pharmacy, New York Presbyterian Hospital, New York City, NY.
Cytomegalovirus (CMV) is an opportunistic infection responsible for profound morbidity and mortality among solid organ transplant recipients. A donor and recipient's CMV IgG serostatus influences…2015 American Transplant Congress
Prediction of Post-Operative Length of Stay and Unplanned Reoperation in Patients Transplanted for Alcoholic Liver Disease: An Artificial Neural Network Approach
Surgery, Vanderbilt University, Nashville, TN.
Purpose:Using artificial neural network (ANN) modeling, this study aims to optimize the prediction of prolonged length of stay (LOS) and need for unplanned reoperation (UR)…2015 American Transplant Congress
Sarcopenia and Non-Ischemic Cardiomyopathy After Liver Transplantation
Introduction: We describe 3 cases of non-ischemic cardiomyopathy (NICM) following liver transplantation (LT) in patients with pre-transplant sarcopenia.Reports: All 3 patients were transplanted at a…2015 American Transplant Congress
Early Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation Has No Negative Impact on Patients outcome'
Liver transplantation (LT) is the only therapeutic option for primary sclerosing cholangitis (PSC), however, recurrence of PSC (rPSC) post-LT occurs at rates ranging from 9-47%.…
American Transplant Congress abstracts